Direct MYD88 gene detection for diffuse large B-cell lymphoma (DLBCL) a miniaturised CRISPR/dCas9-based sensing chip

Traditional methods for single-nucleotide variants based on amplification and fluorescence signals require expensive reagents and cumbersome instruments, and they are time-consuming for each trial. Here, a porous anodised aluminium (PAA)-based sensing chip modified with deactivated Cas9 (dCas9) prot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lab on a chip 2022-02, Vol.22 (4), p.768-776
Hauptverfasser: Sun, Weihan, Guo, Wei, Liu, Zhiyi, Qiao, Sennan, Wang, Ziming, Wang, Jiayu, Qu, Lingxuan, Shan, Liang, Sun, Fei, Xu, Shuping, Bai, Ou, Liang, Chongyang
Format: Artikel
Sprache:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 776
container_issue 4
container_start_page 768
container_title Lab on a chip
container_volume 22
creator Sun, Weihan
Guo, Wei
Liu, Zhiyi
Qiao, Sennan
Wang, Ziming
Wang, Jiayu
Qu, Lingxuan
Shan, Liang
Sun, Fei
Xu, Shuping
Bai, Ou
Liang, Chongyang
description Traditional methods for single-nucleotide variants based on amplification and fluorescence signals require expensive reagents and cumbersome instruments, and they are time-consuming for each trial. Here, a porous anodised aluminium (PAA)-based sensing chip modified with deactivated Cas9 (dCas9) proteins and synthetic guide RNA (sgRNA) as the biorecognition receptor is developed, which can be used for the label-free sensing of the diffuse large B-cell lymphoma (DLBCL) MYD88 L265P gene by integrating with electrochemical ionic current rectification (ICR) measurement. The sgRNA that can specifically identify and capture the MYD88 L265P gene was screened, which has been proved to be workable to activate dCas9 for the target MYD88 L265P . In the sensing process, the dCas9 proteins can capture the genome sequence, thus bringing negative charges over the PAA chip and correspondingly resulting in a variation in the ICR value due to the uneven transport of potassium anions through the ion channels of the PAA chip. The whole sensing can be finished within 40 min, and there is no need for gene amplification. The CRISPR/dCas9-based sensor demonstrates ultrasensitive detection performance in the concentration range of 50 to 200 ng μL −1 and it has been proved to be feasible for the genome sequence of patient tissues. This sensor shows the potential of targeting other mutations by designing the corresponding sgRNAs and expands the applications of CRISPR/dCas9 technology to the on-chip electrical detection of nucleic acids, which will be very valuable for rapid diagnosis of clinically mutated genes. This makes the hybrid CRISPR-PAA chip an ideal candidate for next-generation nucleic acid biosensors. CRISPR/dCas9 technology integrated with electrochemical detection was developed for ultrasensitive and fast gene mutation detection of diffuse large B-cell lymphoma above a dCas9/sgRNA modified porous anodised aluminium sensing chip.
doi_str_mv 10.1039/d1lc01055g
format Article
fullrecord <record><control><sourceid>rsc</sourceid><recordid>TN_cdi_rsc_primary_d1lc01055g</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>d1lc01055g</sourcerecordid><originalsourceid>FETCH-rsc_primary_d1lc01055g3</originalsourceid><addsrcrecordid>eNqFj7FrwkAUhw-xoG1duhfeqEPqHTE1WU0sLSiI7eIk17uX-MrlEu7Fwf_eCtKOTt-P7zd9Qjwp-aJknE2tckYqmSRVTwzVbB5HUqVZ_29n84G4Z_6RUiWz13QouoICmg7WuyJNoUKPYLH7NdR4KJsAlsryyAhOhwphERl0Dtypbg9NrWFcrBb5agIaavKku2MgRgv59uNzs53aXHMWfeuLYvRMvgJzoPZR3JXaMY6ufBDPb8uv_D0KbPZtoFqH0_4_Jb71nwFQUks6</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Direct MYD88 gene detection for diffuse large B-cell lymphoma (DLBCL) a miniaturised CRISPR/dCas9-based sensing chip</title><source>Royal Society Of Chemistry Journals 2008-</source><source>Alma/SFX Local Collection</source><creator>Sun, Weihan ; Guo, Wei ; Liu, Zhiyi ; Qiao, Sennan ; Wang, Ziming ; Wang, Jiayu ; Qu, Lingxuan ; Shan, Liang ; Sun, Fei ; Xu, Shuping ; Bai, Ou ; Liang, Chongyang</creator><creatorcontrib>Sun, Weihan ; Guo, Wei ; Liu, Zhiyi ; Qiao, Sennan ; Wang, Ziming ; Wang, Jiayu ; Qu, Lingxuan ; Shan, Liang ; Sun, Fei ; Xu, Shuping ; Bai, Ou ; Liang, Chongyang</creatorcontrib><description>Traditional methods for single-nucleotide variants based on amplification and fluorescence signals require expensive reagents and cumbersome instruments, and they are time-consuming for each trial. Here, a porous anodised aluminium (PAA)-based sensing chip modified with deactivated Cas9 (dCas9) proteins and synthetic guide RNA (sgRNA) as the biorecognition receptor is developed, which can be used for the label-free sensing of the diffuse large B-cell lymphoma (DLBCL) MYD88 L265P gene by integrating with electrochemical ionic current rectification (ICR) measurement. The sgRNA that can specifically identify and capture the MYD88 L265P gene was screened, which has been proved to be workable to activate dCas9 for the target MYD88 L265P . In the sensing process, the dCas9 proteins can capture the genome sequence, thus bringing negative charges over the PAA chip and correspondingly resulting in a variation in the ICR value due to the uneven transport of potassium anions through the ion channels of the PAA chip. The whole sensing can be finished within 40 min, and there is no need for gene amplification. The CRISPR/dCas9-based sensor demonstrates ultrasensitive detection performance in the concentration range of 50 to 200 ng μL −1 and it has been proved to be feasible for the genome sequence of patient tissues. This sensor shows the potential of targeting other mutations by designing the corresponding sgRNAs and expands the applications of CRISPR/dCas9 technology to the on-chip electrical detection of nucleic acids, which will be very valuable for rapid diagnosis of clinically mutated genes. This makes the hybrid CRISPR-PAA chip an ideal candidate for next-generation nucleic acid biosensors. CRISPR/dCas9 technology integrated with electrochemical detection was developed for ultrasensitive and fast gene mutation detection of diffuse large B-cell lymphoma above a dCas9/sgRNA modified porous anodised aluminium sensing chip.</description><identifier>ISSN: 1473-0197</identifier><identifier>EISSN: 1473-0189</identifier><identifier>DOI: 10.1039/d1lc01055g</identifier><ispartof>Lab on a chip, 2022-02, Vol.22 (4), p.768-776</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Sun, Weihan</creatorcontrib><creatorcontrib>Guo, Wei</creatorcontrib><creatorcontrib>Liu, Zhiyi</creatorcontrib><creatorcontrib>Qiao, Sennan</creatorcontrib><creatorcontrib>Wang, Ziming</creatorcontrib><creatorcontrib>Wang, Jiayu</creatorcontrib><creatorcontrib>Qu, Lingxuan</creatorcontrib><creatorcontrib>Shan, Liang</creatorcontrib><creatorcontrib>Sun, Fei</creatorcontrib><creatorcontrib>Xu, Shuping</creatorcontrib><creatorcontrib>Bai, Ou</creatorcontrib><creatorcontrib>Liang, Chongyang</creatorcontrib><title>Direct MYD88 gene detection for diffuse large B-cell lymphoma (DLBCL) a miniaturised CRISPR/dCas9-based sensing chip</title><title>Lab on a chip</title><description>Traditional methods for single-nucleotide variants based on amplification and fluorescence signals require expensive reagents and cumbersome instruments, and they are time-consuming for each trial. Here, a porous anodised aluminium (PAA)-based sensing chip modified with deactivated Cas9 (dCas9) proteins and synthetic guide RNA (sgRNA) as the biorecognition receptor is developed, which can be used for the label-free sensing of the diffuse large B-cell lymphoma (DLBCL) MYD88 L265P gene by integrating with electrochemical ionic current rectification (ICR) measurement. The sgRNA that can specifically identify and capture the MYD88 L265P gene was screened, which has been proved to be workable to activate dCas9 for the target MYD88 L265P . In the sensing process, the dCas9 proteins can capture the genome sequence, thus bringing negative charges over the PAA chip and correspondingly resulting in a variation in the ICR value due to the uneven transport of potassium anions through the ion channels of the PAA chip. The whole sensing can be finished within 40 min, and there is no need for gene amplification. The CRISPR/dCas9-based sensor demonstrates ultrasensitive detection performance in the concentration range of 50 to 200 ng μL −1 and it has been proved to be feasible for the genome sequence of patient tissues. This sensor shows the potential of targeting other mutations by designing the corresponding sgRNAs and expands the applications of CRISPR/dCas9 technology to the on-chip electrical detection of nucleic acids, which will be very valuable for rapid diagnosis of clinically mutated genes. This makes the hybrid CRISPR-PAA chip an ideal candidate for next-generation nucleic acid biosensors. CRISPR/dCas9 technology integrated with electrochemical detection was developed for ultrasensitive and fast gene mutation detection of diffuse large B-cell lymphoma above a dCas9/sgRNA modified porous anodised aluminium sensing chip.</description><issn>1473-0197</issn><issn>1473-0189</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqFj7FrwkAUhw-xoG1duhfeqEPqHTE1WU0sLSiI7eIk17uX-MrlEu7Fwf_eCtKOTt-P7zd9Qjwp-aJknE2tckYqmSRVTwzVbB5HUqVZ_29n84G4Z_6RUiWz13QouoICmg7WuyJNoUKPYLH7NdR4KJsAlsryyAhOhwphERl0Dtypbg9NrWFcrBb5agIaavKku2MgRgv59uNzs53aXHMWfeuLYvRMvgJzoPZR3JXaMY6ufBDPb8uv_D0KbPZtoFqH0_4_Jb71nwFQUks6</recordid><startdate>20220215</startdate><enddate>20220215</enddate><creator>Sun, Weihan</creator><creator>Guo, Wei</creator><creator>Liu, Zhiyi</creator><creator>Qiao, Sennan</creator><creator>Wang, Ziming</creator><creator>Wang, Jiayu</creator><creator>Qu, Lingxuan</creator><creator>Shan, Liang</creator><creator>Sun, Fei</creator><creator>Xu, Shuping</creator><creator>Bai, Ou</creator><creator>Liang, Chongyang</creator><scope/></search><sort><creationdate>20220215</creationdate><title>Direct MYD88 gene detection for diffuse large B-cell lymphoma (DLBCL) a miniaturised CRISPR/dCas9-based sensing chip</title><author>Sun, Weihan ; Guo, Wei ; Liu, Zhiyi ; Qiao, Sennan ; Wang, Ziming ; Wang, Jiayu ; Qu, Lingxuan ; Shan, Liang ; Sun, Fei ; Xu, Shuping ; Bai, Ou ; Liang, Chongyang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-rsc_primary_d1lc01055g3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Weihan</creatorcontrib><creatorcontrib>Guo, Wei</creatorcontrib><creatorcontrib>Liu, Zhiyi</creatorcontrib><creatorcontrib>Qiao, Sennan</creatorcontrib><creatorcontrib>Wang, Ziming</creatorcontrib><creatorcontrib>Wang, Jiayu</creatorcontrib><creatorcontrib>Qu, Lingxuan</creatorcontrib><creatorcontrib>Shan, Liang</creatorcontrib><creatorcontrib>Sun, Fei</creatorcontrib><creatorcontrib>Xu, Shuping</creatorcontrib><creatorcontrib>Bai, Ou</creatorcontrib><creatorcontrib>Liang, Chongyang</creatorcontrib><jtitle>Lab on a chip</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Weihan</au><au>Guo, Wei</au><au>Liu, Zhiyi</au><au>Qiao, Sennan</au><au>Wang, Ziming</au><au>Wang, Jiayu</au><au>Qu, Lingxuan</au><au>Shan, Liang</au><au>Sun, Fei</au><au>Xu, Shuping</au><au>Bai, Ou</au><au>Liang, Chongyang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Direct MYD88 gene detection for diffuse large B-cell lymphoma (DLBCL) a miniaturised CRISPR/dCas9-based sensing chip</atitle><jtitle>Lab on a chip</jtitle><date>2022-02-15</date><risdate>2022</risdate><volume>22</volume><issue>4</issue><spage>768</spage><epage>776</epage><pages>768-776</pages><issn>1473-0197</issn><eissn>1473-0189</eissn><abstract>Traditional methods for single-nucleotide variants based on amplification and fluorescence signals require expensive reagents and cumbersome instruments, and they are time-consuming for each trial. Here, a porous anodised aluminium (PAA)-based sensing chip modified with deactivated Cas9 (dCas9) proteins and synthetic guide RNA (sgRNA) as the biorecognition receptor is developed, which can be used for the label-free sensing of the diffuse large B-cell lymphoma (DLBCL) MYD88 L265P gene by integrating with electrochemical ionic current rectification (ICR) measurement. The sgRNA that can specifically identify and capture the MYD88 L265P gene was screened, which has been proved to be workable to activate dCas9 for the target MYD88 L265P . In the sensing process, the dCas9 proteins can capture the genome sequence, thus bringing negative charges over the PAA chip and correspondingly resulting in a variation in the ICR value due to the uneven transport of potassium anions through the ion channels of the PAA chip. The whole sensing can be finished within 40 min, and there is no need for gene amplification. The CRISPR/dCas9-based sensor demonstrates ultrasensitive detection performance in the concentration range of 50 to 200 ng μL −1 and it has been proved to be feasible for the genome sequence of patient tissues. This sensor shows the potential of targeting other mutations by designing the corresponding sgRNAs and expands the applications of CRISPR/dCas9 technology to the on-chip electrical detection of nucleic acids, which will be very valuable for rapid diagnosis of clinically mutated genes. This makes the hybrid CRISPR-PAA chip an ideal candidate for next-generation nucleic acid biosensors. CRISPR/dCas9 technology integrated with electrochemical detection was developed for ultrasensitive and fast gene mutation detection of diffuse large B-cell lymphoma above a dCas9/sgRNA modified porous anodised aluminium sensing chip.</abstract><doi>10.1039/d1lc01055g</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1473-0197
ispartof Lab on a chip, 2022-02, Vol.22 (4), p.768-776
issn 1473-0197
1473-0189
language
recordid cdi_rsc_primary_d1lc01055g
source Royal Society Of Chemistry Journals 2008-; Alma/SFX Local Collection
title Direct MYD88 gene detection for diffuse large B-cell lymphoma (DLBCL) a miniaturised CRISPR/dCas9-based sensing chip
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A37%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-rsc&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Direct%20MYD88%20gene%20detection%20for%20diffuse%20large%20B-cell%20lymphoma%20(DLBCL)%20a%20miniaturised%20CRISPR/dCas9-based%20sensing%20chip&rft.jtitle=Lab%20on%20a%20chip&rft.au=Sun,%20Weihan&rft.date=2022-02-15&rft.volume=22&rft.issue=4&rft.spage=768&rft.epage=776&rft.pages=768-776&rft.issn=1473-0197&rft.eissn=1473-0189&rft_id=info:doi/10.1039/d1lc01055g&rft_dat=%3Crsc%3Ed1lc01055g%3C/rsc%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true